Frontier Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.21M | Sell |
39,666
-120
| -0.3% | -$12.7K | 0.04% | 277 |
|
|
2025
Q1 | $4.94M | Buy |
39,786
+4,784
| +14% | +$594K | 0.05% | 255 |
|
|
2024
Q4 | $4.31M | Buy |
35,002
+11,027
| +46% | +$1.36M | 0.04% | 260 |
|
|
2024
Q3 | $2.67M | Sell |
23,975
-441
| -2% | -$49.1K | 0.03% | 262 |
|
|
2024
Q2 | $2.61M | Sell |
24,416
-8,830
| -27% | -$942K | 0.03% | 265 |
|
|
2024
Q1 | $4M | Sell |
33,246
-26,591
| -44% | -$3.2M | 0.04% | 254 |
|
|
2023
Q4 | $7.36M | Buy |
59,837
+1,370
| +2% | +$169K | 0.07% | 217 |
|
|
2023
Q3 | $7.57M | Buy |
58,467
+18,070
| +45% | +$2.34M | 0.08% | 206 |
|
|
2023
Q2 | $5.01M | Sell |
40,397
-19,146
| -32% | -$2.37M | 0.05% | 232 |
|
|
2023
Q1 | $8.71M | Sell |
59,543
-170,583
| -74% | -$25M | 0.09% | 204 |
|
|
2022
Q4 | $36.7M | Buy |
230,126
+69,305
| +43% | +$11M | 0.4% | 100 |
|
|
2022
Q3 | $21.4M | Buy |
160,821
+83,286
| +107% | +$11.1M | 0.25% | 138 |
|
|
2022
Q2 | $12.1M | Buy |
+77,535
| New | +$12.1M | 0.14% | 193 |
|